The North America Microwave Ablation Market would witness market growth of 13.3% CAGR during the forecast period (2022-2028).
Microwaves have the capability of propagating through as well as effectively heating larger volumes of tissues of different types including those with low electrical & thermal conductivity and high impedance. For instance, bone & lung tissues are linked with suboptimal outcomes with radiofrequency because of their high baseline impedance. Similar to RF & laser technologies, microwave ablation technology could readily penetrate via desiccated or charred tissues that are inclined to build up around hyperthermic ablation applicators, which results in limited power delivery to non-microwave energy systems.
More than one microwave antenna could be used together to get the benefit of thermal synergy if placed in widely spaced or close proximity to ablate various tumors in one go. Although multi-applicator ablation is also possible through other power sources, microwave ablation has the ability to power continuously without the need to switch from one electrode to another.
Microwave ablation includes the utilization of a generator that produces an electromagnetic field that is transmitted by an antenna that causes friction and agitation among water molecules which raises the tissues’ temperature up to 60-150°C. If compared to radiofrequency ablation, microwave ablation offers various advantages, including lower heat sink interference, higher temperature production capacity, unaffected by the high impedance of multiple tissues, and less time to be spent for large areas of ablation.
In the United States, HIV is still a public health problem. There were approximately 30,635 people in 2020 who underwent HIV diagnosis in the United States and the rest of the region. This could further result in the rising prevalence of HIV cases. In 2019, in the United States, around 1,752,735 new cases were diagnosed, and about 439 new cancer cases out of every 100,000 people in the region. This rising occurrence of cancer raises the demand for advanced technologies for the treatment of cancer. This would boost the demand for ablation technologies, thereby supporting the market expansion for microwave ablation in the region.
The US market dominated the North America Microwave Ablation Market by Country in 2021; thereby, achieving a market value of $182,193.1 Thousands by 2028. The Canada market is experiencing a CAGR of 15.9% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 14.9% during (2022 - 2028).
Based on End-user, the market is segmented into Hospital, Research Laboratories, and Ambulatory Surgical Centers. Based on Component, the market is segmented into Accessories, Generator, and Power Distribution System. Based on Application, the market is segmented into Oncology, Cardiology, Urology, Orthopedic, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Microwave Ablation Market is Predict to reach $696.6 Million by 2028, at a CAGR of 14.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Varian Medical Systems, Inc. (Siemens Healthineers AG), AngioDynamics, Inc., Medtronic PLC, Johnson & Johnson (Johnson & Johnson Services, Inc.), Terumo Corporation, Emblation Limited, HUBER+SUHNER AG, MedWaves, Inc., SympleSurgical, Inc. and Mermaid Medical Group.
By End-user
By Component
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 